Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
Public ClinicalTrials.gov record NCT01556490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC)
Study identification
- NCT ID
- NCT01556490
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Enrollment
- 526 participants
Conditions and interventions
Conditions
Interventions
- TheraSphere Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2012
- Primary completion
- Apr 29, 2022
- Completion
- Apr 29, 2022
- Last update posted
- Nov 7, 2023
2012 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner - University Medical Center Phoenix | Phoenix | Arizona | 85006-2612 | — |
| H Lee Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Northshore Hospital | Evanston | Illinois | 60201 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| Wayne State Harper Hospital | Detroit | Michigan | 48201 | — |
| Mayo Clinic Cancer Center | Rochester | Minnesota | 55905 | — |
| Weill Cornell Medical Center | New York | New York | 10021 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Miami Valley Hospital | Dayton | Ohio | 45409 | — |
| Legacy Meridian Park Medical Center | Tualatin | Oregon | 97062 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| St Marks Hospital | Salt Lake City | Utah | 84124 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | — |
| Sentra Norfolk General Hospital | Norfolk | Virginia | 23507 | — |
| Seattle Cancer Care Alliance/University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01556490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01556490 live on ClinicalTrials.gov.